Eyenovia Inc. - רווח נקי למניה אחת בשנים עשר החודשים האחרונים EYEN

Eyenovia, Inc. (EYEN) is creating a closed-loop precision ophthalmology system based on Optejet, earning its status as a leading medical innovator. This annual EPS TTM percentage growth chart illustrates profit dynamics, where the current figure stands at -18.20. Top-tier engineers and physicians are driving the project's development, focusing on the successful completion of clinical trials and the commercialization of unique microdosing products.
Eyenovia Corp - פילוחים אנליטיים ומדדי מפתח (EYEN)

Year-over-year EPS growth (TTM) reflects the annual rate of change in net income per share over the last twelve months for Eyenovia, Inc. (EYEN). The current value of -18.20 demonstrates the efficiency of asset monetization. Stable utilization of ophthalmological production lines directly impacts the calculation base of this indicator. By analyzing the historical trend of year-over-year EPS (over 12 months), an investor assesses the business's resilience to market shocks. Ignoring negative trends in this curve creates a critical risk of capital drawdown.